EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The role of postoperative radiotherapy or chemoradiation in pT1-2N1M0 oral squamous cell carcinoma

Chan-Chi Chang, Yin-Ting Wu, Hsi-Huei Lu, Yung-Jen Cheng, Mu-Hung Tsai

Journal of the Formosan Medical Association · 2025

DOI: 10.1016/j.jfma.2024.03.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Formosan Medical Association, 2025. Verfasst von Chan-Chi Chang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Hauptthemen laut MEDLINE: Mouth Neoplasms, Chemoradiotherapy, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cheng Kung University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Postoperative radiotherapy (PORT) and concurrent chemoradiation (CCRT) are indicated for patients with advanced oral cancer. However, the benefits for pT1-2N1 disease without adverse pathological features are controversial. METHODS: This retrospective study using the Taiwan Cancer Registry database included patients with pT1-2N1 oral cancer from January 1, 2011, to December 31, 2017. Overall survival was analyzed in patients receiving surgery alone, PORT, or CCRT. RESULTS: Among the 862 patients, the five-year overall survival rate in patients receiving surgery alone, PORT, and CCRT was 62.2%, 58.7%, and 71.1% (P = 0.03), respectively. CCRT was associated with longer survival than PORT (P = 0.008). Survival in patients with pT2 disease was significantly higher with CCRT than PORT (P = 0.001), but no difference was observed in pT1 disease. CONCLUSION: CCRT demonstrated a favorable impact on survival outcomes in patients diagnosed with pT2N1 oral cancer when compared to PORT. However, no significant survival benefits were observed for patients with pT1 disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsChemoradiotherapyCarcinoma, Squamous CellHumansMaleFemaleRetrospective StudiesMiddle AgedAgedTaiwanAdultNeoplasm StagingSurvival RateRegistriesAged, 80 and overRadiotherapy, Adjuvant

Stichwörter der Autor:innen

ChemotherapyOral cavityRadiation therapy

Autor:innen und Institutionen

  • Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Division of Nuclear Medicine, Department of Medical Imaging, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Radiation Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Radiation Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Institute of Computer Science and Information Engineering, National Cheng K…

Förderung

  • National Cheng Kung University Hospital

Zitieren

APA

Chang, C. C., Wu, Y. T., Lu, H. H., Cheng, Y. J., & Tsai, M. H. (2025). The role of postoperative radiotherapy or chemoradiation in pT1-2N1M0 oral squamous cell carcinoma. Journal of the Formosan Medical Association. https://doi.org/10.1016/j.jfma.2024.03.005

Vancouver

Chang CC, Wu YT, Lu HH, Cheng YJ, Tsai MH. The role of postoperative radiotherapy or chemoradiation in pT1-2N1M0 oral squamous cell carcinoma. Journal of the Formosan Medical Association. 2025. doi:10.1016/j.jfma.2024.03.005

BibTeX
@article{Chang2025,
  author = {Chang, Chan-Chi and Wu, Yin-Ting and Lu, Hsi-Huei and Cheng, Yung-Jen and Tsai, Mu-Hung},
  title = {The role of postoperative radiotherapy or chemoradiation in pT1-2N1M0 oral squamous cell carcinoma},
  journal = {Journal of the Formosan Medical Association},
  year = {2025},
  doi = {10.1016/j.jfma.2024.03.005}
}
Kostenlos starten →